Physician profile
Xiaohuan Li
NPI 1225425333
$1,684.39
in general payments reported to CMS, 2019-2025
15 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $28.88 · 2021: $145 · 2022: $200 · 2023: $261 · 2024: $407 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,192.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $523.67 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $384.29 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $177.32 | 2024-2025 | |
| Lilly USA, LLC | $129.53 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Allergan, INC. | $104.71 | 2019 | |
| Janssen Pharmaceuticals, INC | $64.46 | 2020-2024 | Spravato |
| Merck Sharp & Dohme LLC | $58.93 | 2023-2024 | Gardasil 9, Gardasil, Capvaxive |
| Exact Sciences Corporation | $55.65 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $54.05 | 2024 | Freestyle Libre 3 |
| Pfizer INC. | $36.05 | 2023-2024 | |
| Organon LLC | $34.83 | 2022 | |
| Dexcom, INC. | $17.51 | 2025 | Dexcom G6 Transmitter |
| Sonex Health, INC. | $15.73 | 2023 | Sx-One Microknife |
| Medtronic Vascular, INC. | $14.05 | 2020 | |
| Genentech USA, INC. | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaohuan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.